NCT00002637View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 1995

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

gene-modified tumor cell vaccine therapy

BIOLOGICAL

recombinant interferon gamma

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002637 - Biological Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter